Pre-Survey of CTCAE in Oncology Nurses and APPs Question Title * 1. What type of oncology nursing role do you currently fulfill? Oncology Infusion Nurse Outpatient oncology nurse, Nurse navigator, Coordinator Inpatient Oncology Nurse Triage Nurse Oncology Research Nurse Oncology Advanced Practice Provider Question Title * 2. How likely are you to report adverse events to the provider using the CTCAE? Likely Neither likely nor unlikely Unlikely Question Title * 3. How familiar are you with using the CTCAE tool and how to grade an adverse event? Extremely familiar Somewhat familiar Not at all familiar Question Title * 4. If you do not use the CTCAE criteria to grade adverse event severity, why not? Not required Time constraints Not trained on the tool Not part of our current documentation workflow N/A - Currently use the CTCAE tool Other (please specify) Question Title * 5. Does your facility provide patients with the Patient Reported Outcome -CTCAE for patient reporting of adverse event? Yes No Unsure Question Title * 6. Does your electronic medical record system provide a drop-down option for selecting grading of an adverse event when charting? Yes, and required to use it Yes, but not required to use it No Unsure Question Title * 7. What does CTCAE stand for and who published it? Critical Timing for Cancer's Adverse Events, SITC Cancer Teams Criteria for Adverse Events, NCCN Common Terminology Criteria of Assessment and Evaluation, NIH Common Terminology Criteria for Adverse Events, NCI Question Title * 8. What is CTCAE? Terms of symptoms patients experience before being diagnosed with cancer Terms used in oncology that identify classes of cancer treatment Standardized definitions for adverse events to describe the severity of organ toxicity in patients receiving cancer therapy Criteria you have to meet to receive an oncology treatment Question Title * 9. Why is it important for oncology nurses and advanced practice providers to use the CTCAE tool when grading adverse events? Check all that apply. It is a standardized way to report adverse events without being subjective for all oncology patients Knowing the severity of the adverse event helps with initiating appropriate management It is required to be used in clinical trials for oncology To assist advanced practice providers in using appropriate billing Question Title * 10. What does the dash “ – “ signify when examining the descriptors within the grade? Not a significant adverse event Grade not available And Unsure Question Title * 11. What does the semicolon signify when examining the descriptors within the grade? And Or None Unsure Question Title * 12. The patient is a 59 year old female here for her 3rd infusion for her melanoma, and reports overall feeling well. Her energy has been fair and she completes her ADLs without difficulty. Her daughter who is her caregiver tells you that she has noticed her mom being more short of breath when walking to the car and in the store, and has an occasional dry cough. Her baseline sitting and ambulating POX is 98% on room air, but today, she is 95% sitting and 92% with ambulation. You notice after returning from the ambulating POX she is experiencing dyspnea. You are concerned that she may be developing pneumonitis and should report this to her care team immediately to determine the appropriate evaluation and intervention. Based on her symptoms, what grade of pneumonitis do you report to her care team?Pneumonitis Definition: A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma.Grade 1- Asymptomatic; clinical or diagnostic observations only; intervention not indicatedGrade 2- Symptomatic; medical intervention indicated; limiting instrumental ADLGrade 3-Severe symptoms; limiting self-care ADL; oxygen indicatedGrade 4-Life-threatening respiratory compromise; urgent intervention indicated (e.g., tracheotomy or intubation)Grade 5-Death Grade 1 Grade 2 Grade 3 Grade 4 Grade 5 Done